ASCRS 20/Happy is no longer available for CME credit.
Accreditation Statement
The American Society of Cataract and Refractive Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ASCRS takes responsibility for the content, quality and scientific integrity of the CME activity.
Designation Statement
The American Society of Cataract and Refractive Surgery designates the 20-Happy in 2020 curriculum within this online educational activity for a maximum of 18 AMA PRA Category 1 Credits TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
All CME activities approved for AMA PRA Category 1 Credits TM are valid for recognition by the European Accreditation Council for Continuing Medical Education (EACCME). Physicians not licensed in the U.S. who participate in this CME activity are eligible for AMA PRA Category 1 Credits TM
Target Audience
All ophthalmologists interested in improving their skills for refractive IOL implantation (residents, comprehensive ophthalmologists, refractive cataract surgeons, staff members and administrators)
Educational Objectives
Upon completion of the 20 Happy Curriculum, participants should be able to:
- Illustrate evidence-based approaches for hitting the refractive target, eliminating most astigmatism and enhancing the refractive outcome postoperatively.
- Compare refractive IOLs and provide practical pearls and pitfalls for implanting different refractive IOLs; to include adjunct surgical technologies.
- Examine preoperative diagnostics and discuss selecting patients and determining the best individual refractive IOL choice.
- Outline how to establish or enhance a refractive IOL practice and how to improve communication efficacy.
- Employ tips for office and organization workflow that are specific to the evaluation and counseling of a refractive IOL patient.
- Discuss management of an unhappy refractive IOL patient and refractive or surgical complications.
Notice About Off-Label Use Presentations
The ASCRS Annual Meeting may include presentations on drugs or devices or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. ASCRS is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASCRS of the uses, products or techniques presented.